NCT00679146View on ClinicalTrials.gov

Efficacy Safety of a Combination Thiocolchicoside+Ketoprofen Compared to Thiocolchicoside Twice a Day for 7 Days in Patients Suffering From Acute Non Specific Low Back Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

334

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Low Back Pain
Interventions
DRUG

Thiocolchicoside+Ketoprofen

1 tablet TCC 8 mg + ketoprofen 100 mg b.i.d + 2 tablets TCC placebo b.i.d

DRUG

Thiocolchicoside

2 tablets TCC 4 mg b.i.d. + 1 tablet of FDC placebo b.i.d

Trial Locations (6)

Unknown

Sanofi-Aventis Administrative Office, São Paulo

Sanofi-Aventis Administrative Office, Bogotá

Sanofi-Aventis Administrative Office, Cairo

Sanofi-Aventis Administrative Office, Guatemala City

Sanofi-Aventis Administrative Office, Col. Coyoacan

Sanofi-Aventis Administrative Office, Caracas

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00679146 - Efficacy Safety of a Combination Thiocolchicoside+Ketoprofen Compared to Thiocolchicoside Twice a Day for 7 Days in Patients Suffering From Acute Non Specific Low Back Pain | Biotech Hunter | Biotech Hunter